Elinzanetant Patent Expiration
Elinzanetant was first introduced by Bayer Healthcare Pharmaceuticals Inc
Elinzanetant Patents
Given below is the list of patents protecting Elinzanetant, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Lynkuet | US12533358 | May 14, 2045 | Bayer Hlthcare | |
| Lynkuet | US10774091 | Soft Gelatin Capsule Formulation | Mar 13, 2039 | Bayer Hlthcare |
| Lynkuet | US11787820 | Method Of Treating Certain Sex Hormone-Dependent Diseases Administering A Soft Gelatin Capsule Comprising Nk1 And Nk3 Receptors Antagonists | Mar 13, 2039 | Bayer Hlthcare |
| Lynkuet | US12264164 | Method Of Treatment Of Symptoms Of Menopause | Mar 13, 2039 | Bayer Hlthcare |
| Lynkuet | US10195205 | Uses Of Dual Nk1/Nk3 Receptor Antagonists For Treating Sex-Hormone Diseases | May 18, 2036 | Bayer Hlthcare |
| Lynkuet | US7683056 | Pyridine Derivatives And Their Use In The Treatment Of Psychotic Disorders | Sep 15, 2026 | Bayer Hlthcare |
Elinzanetant's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List